Key facts
- This page summarizes Francis E. Odonnell Jr.'s Form 3 filing for Inhibitor Therapeutics, Inc. (INTI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Dec 2022, 20:33.
Francis E. Odonnell Jr. - 13 Dec 2022 Form 3 Insider Report for Inhibitor Therapeutics, Inc. (INTI)
- Reporting relationship
- Chief Executive Officer, Executive Chairman of the Board, Director, 10%+ Owner
- Issuer ticker
- INTI
- Reported as of
- 13 Dec 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 22 Dec 2022, 20:33:18 UTC
- Next SEC filing
- 04 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Francis O'Donnell
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Francis E. Odonnell Jr. filed Form 3 for Inhibitor Therapeutics, Inc. (INTI) on 22 Dec 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INTI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 85,627,069
- Date
- 13 Dec 2022
- Ownership
- See Footnotes
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These shares represent 6,000,000 shares of common stock held by Hopkins Capital Group II, LLC ("HCG II LLC") and 79,627,069 shares of common stock held by Hedgepath, LLC ("HP LLC").
Footnote F2
Francis E. O'Donnell Irrevocable Trust #1 owns 28.12% of HCG II LLC and Francis E. O'Donnell Descendants Trust owns 3.13% of HCG II LLC. Kathleen M . O'Donnell, Dr. O'Donnell's sister, is the trustee of Francis E. O'Donnell Irrevocable Trust #1 and Francis E. O'Donnell Descendants Trust. Dr. O'Donnell does not have voting and dispositive control over any of these shares and disclaims any beneficial ownership of the reported shares held by HCG II LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
Footnote F3
The Francis E. O'Donnell Jr. Irrevocable Trust #7 owns 26.5% of HP LLC. Kathleen M. O'Donnell, Dr. O'Donnell's sister, is the trustee of HP LLC. Dr. O'Donnell does not have voting and dispositive control over any of these shares and disclaims any beneficial ownership of the reported shares held by HP LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
SEC remarks
Chief Executive Officer, Executive Chairman of the Board